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The draft genome sequence of a ristocetin-producing Amycolatopsis strain (sp. MJM2582) isolated in South Korea is reported
here. This strain has a genome of approximately 8.9 Mb containing 7,933 predicted genes, including the ristocetin cluster and 32
additional predicted secondary metabolite biosynthesis clusters.
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Amycolatopsis sp. MJM2582 was isolated from a rhizospheresample from Ami Mountain in Chungcheongnam-do prov-
ince (located in the western part of South Korea) during a screen-
ing for producers of glycopeptide antibiotics and was subse-
quently observed to produce ristocetin (1). Glycopeptides are an
important class of antibiotics that are particularly effective against
Gram-positive bacteria. This family also includes vancomycin, an
antibiotic of last resort which is reserved for the treatment of se-
rious infections that are resistant to other antibiotics, for example,
methicillin-resistant Staphylococcus aureus (MRSA) (2). The sp.
MJM2582 has been shown to produce a number of different ris-
tocetin derivatives, but ristocetin A is the most abundant product
(1). Ristocetin A is a type III glycopeptide antibiotic and possesses
a distinctive branched tetrasaccharide structure. Strain Amycola-
topsis sp. MJM2582 is therefore an alternative natural source of
ristocetin to the original Amycolatopsis lurida isolate, which is the
current commercial producer of ristocetin A (3). Although a toxic
side effect on platelet aggregation led to the discontinuation of
ristocetin A as a antimicrobial (4), the aglycone of ristocetin A has
been found to be free of this undesirable activity and, more signif-
icantly, exhibits improved antimicrobial activity compared with
the parent compound (5). Here, we report the draft sequence of
Amycolatopsis sp. MJM2582, in which we have identified 33 sec-
ondarymetabolite biosynthetic clusters, including the ristocetin A
cluster (GenBank accession number KF882511) (1).
The genome of Amycolatopsis sp. MJM2582 was sequenced us-
ing IlluminaMiSeq to a coverage depth of 83-fold and then assem-
bled using the GS De Novo Assembler (Newbler software version
2.8). The assembled genome comprised a total of 13 large contigs.
The average size of these large contigs is 687,568 bp, and the largest
contig is 2,111,476 bp in length. The estimated size of the genome
is 8,932,977 bpwith an averageGC content of 68.84%. The draft
genome sequence was annotated using the Prokaryotic Genome
Annotation Pipeline (PGAP) with GeneMarkS (6, 7), which
predicted 7,933 coding sequence (CDS) regions, 41 pseudogenes,
54 tRNAs, 14 noncoding RNAs (ncRNAs), and a single copy each
of 5S rRNA, 23S rRNA, and 16S rRNA. The 16S rRNA sequence of
Amycolatopsis sp. MJM2582 showed 99% identity to that of A. lu-
rida, the producer of commercial ristocetin, but phylogenic anal-
ysis indicated that A. sp. CMU-PLA03 is actually taxonomically
themost closely related strain toAmycolatopsis sp.MJM2582. An-
tiSMASH (8) was used to predict potential secondary metabolite
synthetic gene clusters. In addition to the 39 open-reading frames
(ORFs) of the ristocetin A cluster, gene clusters predicted to en-
code the production of lantipeptides, NRPS (nonribosomal pep-
tide synthease) compounds, terpenes, type I polyketide antibiot-
ics, bacteriocins, ectoine, and several unknown metabolites were
identified.
Nucleotide sequence accession numbers. The draft genome
sequence ofAmycolatopsis sp.MJM2582 has been deposited in the
DDBJ/EMBL/GenBank database under the accession number
JPLW00000000. The version described in this paper is version
JPLW01000000.
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